Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment

di Revicki Dennis A, van den Eertwegh Alfons JM, Lorigan Paul, Lebbe Celeste, Linette Gerald, Ottensmeier Christian H, Safikhani Shima, Messina Marianne, Hoos Axel, Wagner Samuel, Kotapati Srividya
Pubblicazione 2012-06-01

Health related quality of life outcomes for unresectable stage III or IV melanoma patients receiving ipilimumab treatment

di Revicki, Dennis A, van den Eertwegh, Alfons JM, Lorigan, Paul, Lebbe, Celeste, Linette, Gerald, Ottensmeier, Christian H, Safikhani, Shima, Messina, Marianne, Hoos, Axel, Wagner, Samuel, Kotapati, Srividya
Pubblicazione 2012

Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition

di Oosterhoff, Dinja, Lougheed, Sinéad, van de Ven, Rieneke, Lindenberg, Jelle, van Cruijsen, Hester, Hiddingh, Lotte, Kroon, Jan, van den Eertwegh, Alfons J.M., Hangalapura, Basav, Scheper, Rik J., de Gruijl, Tanja D.
Pubblicazione 2012

Induction of dendritic cell maturation in the skin microenvironment by soluble factors derived from colon carcinoma

di Lindenberg, Jelle J, van de Ven, Rieneke, Oosterhoff, Dinja, Sombroek, Claudia C, Lougheed, Sinéad M, Stam, Anita GM, Koenen, Hans JPM, van den Eertwegh, Alfons JM, Scheper, Rik J, de Gruijl, Tanja D
Pubblicato in Hum Vaccin Immunother (2014)

Myeloid derived suppressor and dendritic cell subsets are related to clinical outcome in prostate cancer patients treated with prostate GVAX and ipilimumab

di Santegoets, Saskia JAM, Stam, Anita GM, Lougheed, Sinéad M, Gall, Helen, Jooss, Karin, Sacks, Natalie, Hege, Kristen, Lowy, Israel, Scheper, Rik J, Gerritsen, Winald R, van den Eertwegh, Alfons JM, de Gruijl, Tanja D
Pubblicato in J Immunother Cancer (2014)

Vemurafenib plus cobimetinib in unresectable stage IIIc or stage IV melanoma: response monitoring and resistance prediction with positron emission tomography and tumor characterist...

di van der Hiel, Bernies, Haanen, John B.A.G., Stokkel, Marcel P.M., Peeper, Daniel S., Jimenez, Connie R., Beijnen, Jos H., van de Wiel, Bart A., Boellaard, Ronald, van den Eertwegh, Alfons J.M.
Pubblicato in BMC Cancer (2017)

Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an Adenovirus based melanoma vaccine

di Hangalapura, Basav N, Oosterhoff, Dinja, Gupta, Tarun, de Groot, Jan, Wijnands, Pepijn GJTB, van Beusechem, Victor W., den Haan, Joke, Tüting, Thomas, van den Eertwegh, Alfons JM, Curiel, David T, Scheper, Rik J, de Gruijl, Tanja D
Pubblicazione 2011

IL-21 promotes the expansion of CD27(+)CD28(+) tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells

di Santegoets, Saskia JAM, Turksma, Annelies W, Suhoski, Megan M, Stam, Anita GM, Albelda, Steve M, Hooijberg, Erik, Scheper, Rik J, van den Eertwegh, Alfons JM, Gerritsen, Winald R, Powell, Daniel J, June, Carl H, de Gruijl, Tanja D
Pubblicazione 2013

Functional characterization of a STAT3-dependent dendritic cell-derived CD14(+) cell population arising upon IL-10-driven maturation

di Lindenberg, Jelle J., van de Ven, Rieneke, Lougheed, Sinéad M., Zomer, Anoek, Santegoets, Saskia J.A.M., Griffioen, Arjan W., Hooijberg, Erik, van den Eertwegh, Alfons J.M., Thijssen, Victor L., Scheper, Rik J., Oosterhoff, Dinja, de Gruijl, Tanja D.
Pubblicazione 2013

Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Castration-Resistant Prostate Cancer Patients Treated with Abiraterone

di Attard, Gerhardt, de Bono, Johann S., Logothetis, Christopher J., Fizazi, Karim, Mukherjee, Som D., Joshua, Anthony M., Schrijvers, Dirk, van den Eertwegh, Alfons J.M., Li, Weimin, Molina, Arturo, Griffin, Thomas W., Kheoh, Thian, Ricci, Deborah S., Zelinsky, Kathy, Rathkopf, Dana E., Scher, Howard I., Ryan, Charles J.
Pubblicato in Clin Cancer Res (2015)

T cell infiltration on local CpG-B delivery in early-stage melanoma is predominantly related to CLEC9A(+)CD141(+) cDC1 and CD14(+) antigen-presenting cell recruitment

di Koster, Bas D, López González, Marta, van den Hout, Mari FCM, Turksma, Annelies W, Sluijter, Berbel JR, Molenkamp, Barbara G, van Leeuwen, Paul AM, Vosslamber, Saskia, Scheper, Rik J, van den Eertwegh, Alfons JM, van den Tol, M Petrousjka, Jordanova, Ekaterina J, de Gruijl, Tanja D
Pubblicato in J Immunother Cancer (2021)

Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival

di De Remigis, Alessandra, de Gruijl, Tanja D, Uram, Jennifer N, Tzou, Schey-Cherng, Iwama, Shintaro, Talor, Monica V, Armstrong, Todd D, Santegoets, Saskia J A M, Slovin, Susan F, Zheng, Lei, Laheru, Daniel A, Jaffee, Elizabeth M, Gerritsen, Winald R, van den Eertwegh, Alfons JM, Le, Dung T, Caturegli, Patrizio
Pubblicazione 2014

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

di Hodi, F. Stephen, O’Day, Steven J., McDermott, David F., Weber, Robert W., Sosman, Jeffrey A., Haanen, John B., Gonzalez, Rene, Robert, Caroline, Schadendorf, Dirk, Hassel, Jessica C., Akerley, Wallace, van den Eertwegh, Alfons J.M., Lutzky, Jose, Lorigan, Paul, Vaubel, Julia M., Linette, Gerald P., Hogg, David, Ottensmeier, Christian H., Lebbé, Celeste, Peschel, Christian, Quirt, Ian, Clark, Joseph I., Wolchok, Jedd D., Weber, Jeffrey S., Tian, Jason, Yellin, Michael J., Nichol, Geoffrey M., Hoos, Axel, Urba, Walter J.
Pubblicazione 2010

Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?

di Schouwenburg, Maartje G., Suijkerbuijk, Karijn P.M., Koornstra, Rutger H.T., Jochems, Anouk, van Zeijl, Michiel C.T., van den Eertwegh, Alfons J.M., Haanen, John B.A.G., Aarts, Maureen J.B., van Akkooi, Alexander C.J., van den Berkmortel, Franchette W.P.J., de Groot, Jan Willem B., Hospers, Geke A.P., Kapiteijn, Ellen, Kruit, Wim H., Piersma, Djura, van Rijn, Rozemarijn S., ten Tije, Albert J., Vreugdenhil, Gerard, van der Hoeven, Jacobus J.M., Wouters, Michel W.J.M.
Pubblicato in Cancers (Basel) (2019)